Emmaus Life Sciences, Inc.

EMMA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G/A Feb 4, 2025
8-K Nov 19, 2024 CURRENT REPORT
10-Q Nov 19, 2024 10-Q
NT 10-Q Nov 14, 2024 NOTIFICATION OF LATE FILING
8-K Nov 6, 2024 CURRENT REPORT
8-K Oct 25, 2024 CURRENT REPORT
3 Oct 9, 2024 3
8-K Oct 4, 2024 CURRENT REPORT
4 Sep 18, 2024 4
8-K Sep 10, 2024 FORM 8-K
10-Q Sep 10, 2024 10-Q
10-Q Sep 10, 2024 10-Q
NT 10-Q Aug 15, 2024 NT 10-Q
8-K Jul 17, 2024 CURRENT REPORT
8-K Jul 3, 2024 CURRENT REPORT
10-K Jul 3, 2024 10-K
8-K May 28, 2024 CURRENT REPORT
NT 10-K Apr 1, 2024 NOTIFICATION OF LATE FILING
4 Feb 29, 2024 FORM 4 SUBMISSION
8-K Feb 26, 2024 CURRENT REPORT
4 Feb 5, 2024 FORM 4 SUBMISSION
4 Feb 5, 2024 FORM 4 SUBMISSION
4 Feb 5, 2024 FORM 4 SUBMISSION
4 Feb 5, 2024 FORM 4 SUBMISSION
4 Feb 5, 2024 FORM 4 SUBMISSION
← Newer Page 2 of 50 · 1238 filings Older →